Bone Biologics Corp reports a Return on Equity (ROE) of -61.20%.

What is BBLG's dividend yield?

Bone Biologics Corp offers a dividend yield of 0.00%.

What is BBLG's Quality Score?

Our AI rates BBLG's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BBLG?

Our AI Timing Score for BBLG is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BBLG belong to?

Bone Biologics Corp is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Bone Biologics Corp (BBLG) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

BBLG AI Analysis Summary

Our AI summary for BBLG: Bone Biologics Corp (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -61.20%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BBLG

Bone Biologics Corp

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 0.98

0.03 (3.69%) Day Change

Watchlist Portfolio Compare Chart

0.07

D/E

-61.2%

ROE

-57.4%

ROA

0.00%

Div Yield

BONE BIOLOGICS CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.98 Price 0.03 (3.69%) Day Change	NEWS SCORE: 99

BBLG, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.98
PBV / Sector	0.37 / 44,105.10 GREAT
Earning Per Share	-1.64

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	0.04 M GREAT
Average 1W Daily Value	0.05 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-57.40 / 185,260.64
ROA Average (%) / Sector	-94.88 / 36,684.64
ROA Change Average (%) / Sector	292.96 / 422,221.42 GREAT
ROE (%) / Sector	-61.20 / 243,761.81
ROE Average (%) / Sector	-113.98 / 48,758.38
ROE Change Average (%) / Sector	256.66 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 07:59:41
Symbol	BBLG
Name	BONE BIOLOGICS CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	1.81 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1.71 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2 Burlington Woods Drive, Burlington, MA, United States, 01803

Phone: 781 552 4452

Website: https://www.bonebiologics.com

Sector: Healthcare >> Biotechnology

Description: Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.